-+ 0.00%
-+ 0.00%
-+ 0.00%

FOSUN PHARMACEUTICAL SAYS COULD RECEIVE UP TO $362.5 MLN PER PROJECT IF CLAVIS BIO EXERCISES OPTION

Reuters·12/18/2025 10:33:05

Please log in to view news